← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2004Last known activity
Jan 1, 2020
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT04325685Lead sponsorN/AJan 1, 2020
- NCT04325685Reponsible party - principal investigatorN/AJan 1, 2020
- NCT02771418Reponsible party - principal investigatorN/AFeb 1, 2015
- NCT02771418Lead sponsorN/AFeb 1, 2015
- NCT00678418Overall official - principal investigatorPhase 3Jun 1, 2008
- NCT00159510Overall official - principal investigatorPhase 1Apr 1, 2004
- NCT00159510Lead sponsorPhase 1Apr 1, 2004
- NCT00159510Reponsible party - principal investigatorPhase 1Apr 1, 2004
Details
- Last known activity
- Jan 1, 2020